Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000353569-19-000060
Filing Date
2019-10-31
Accepted
2019-10-30 18:29:48
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20190930x10q.htm   iXBRL 10-Q 1396973
2 EXHIBIT 31.1 qdel-ex31120190930xq3.htm EX-31.1 12915
3 EXHIBIT 31.2 qdel-ex31220190930xq3.htm EX-31.2 12998
4 EXHIBIT 32.1 qdel-ex32120190930xq3.htm EX-32.1 6742
  Complete submission text file 0000353569-19-000060.txt   6698138

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20190930.xsd EX-101.SCH 39792
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20190930_cal.xml EX-101.CAL 95366
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20190930_def.xml EX-101.DEF 177081
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20190930_lab.xml EX-101.LAB 640234
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20190930_pre.xml EX-101.PRE 369466
17 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20190930x10q_htm.xml XML 1158881
Mailing Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-10961 | Film No.: 191181453
SIC: 2835 In Vitro & In Vivo Diagnostic Substances